BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38217846)

  • 1. Determining a urinary-specific antibiogram and risk factors of trimethoprim/sulfamethoxazole, ciprofloxacin and multidrug resistance among Enterobacterales in primary care.
    Valentine-King M; Hansen MA; Zoorob R; Schlueter M; Matas JL; Willis SE; Danek LCK; Muldrew K; Zare M; Hudson F; Atmar RL; Chou A; Trautner BW; Grigoryan L
    J Antimicrob Chemother; 2024 Mar; 79(3):559-563. PubMed ID: 38217846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
    Valentine-King M; Zoorob R; Grigoryan L; Trautner B
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
    Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
    Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Antibiotic Susceptibility Among Patients With Recurrent Urinary Tract Infection Using a Prior Culture.
    Valentine-King MA; Trautner BW; Zoorob RJ; Salemi JL; Gupta K; Grigoryan L
    J Urol; 2024 Jan; 211(1):144-152. PubMed ID: 37820311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACTERIAL PROFILE, ANTIMICROBIAL RESISTANCE, AND FACTORS ASSOCIATED WITH URINARY TRACT INFECTION AMONG PREGNANT WOMEN AT HOSANNA TOWN HEALTH FACILITIES, CENTRAL ETHIOPIA.
    Mussema A; Admasu D; Bawore S; Abdo R; Seid A
    Georgian Med News; 2023 Sep; (342):113-121. PubMed ID: 37991965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
    J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
    McGregor JC; Elman MR; Bearden DT; Smith DH
    BMC Fam Pract; 2013 Feb; 14():25. PubMed ID: 23433241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
    Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
    J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.
    Olson RP; Harrell LJ; Kaye KS
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1285-6. PubMed ID: 19104022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-Vitro Biofilm Formation and Antimicrobial Resistance of
    Raya S; Belbase A; Dhakal L; Govinda Prajapati K; Baidya R; Kishor Bimali N
    Biomed Res Int; 2019; 2019():1474578. PubMed ID: 31641666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Virulence Markers With Resistance to Oral Antibiotics in Escherichia coli Isolates Causing Uncomplicated Community-Acquired Cystitis.
    Radera S; Agarwal J; Srivastava S; Gupta P; Pandey A
    Cureus; 2023 May; 15(5):e39458. PubMed ID: 37362452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012.
    Sanchez GV; Babiker A; Master RN; Luu T; Mathur A; Bordon J
    Antimicrob Agents Chemother; 2016 May; 60(5):2680-3. PubMed ID: 26883714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial etiology of urinary tract infections in patients treated at Kenyan health facilities and their resistance towards commonly used antibiotics.
    Kiiru S; Maina J; Katana J; Mwaniki J; Asiimwe BB; Mshana SE; Keenan K; Gillespie SH; Stelling J; Holden MTG; ; Kiiru J
    PLoS One; 2023; 18(5):e0277279. PubMed ID: 37235625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
    Zhanel GG; Karlowsky JA; Harding GK; Carrie A; Mazzulli T; Low DE; Hoban DJ
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1089-92. PubMed ID: 10722520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.